Login to Your Account



Pharma: Other News To Note


Friday, April 6, 2012
• Teva Pharmaceutical Industries Ltd., of Jerusalem, said the FDA decided the firm is sole first-to-file for both Orange Book patents listed for wakefulness drug Provigil (modafinil) and, therefore, Teva's abbreviated new drug application alone is entitled to 180-day exclusivity.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription